1. CPMP EU-wide reviews for COX-2 inhibitors and loratadine finalised

   Media release 23 January 2013 Pages: 2 - 2

2. DoTS: a new classification system for ADRs

   Comment 23 January 2013 Pages: 2 - 2

3. Epoetin alfa: increased risk of VT

   Clinical study 23 January 2013 Pages: 3 - 3

4. Moxonidine SR in HF associated with excess mortality

   Clinical study 23 January 2013 Pages: 3 - 3

5. Nicotine treatment is poorly tolerated by patients with PD

   Clinical study 23 January 2013 Pages: 3 - 3

6. Screening test criteria should apply to ADR monitoring

   Comment 23 January 2013 Pages: 3 - 3

7. Androgen suppression affects cognitive function in men with prostate cancer

   Clinical study 23 January 2013 Pages: 4 - 4

8. Gastric acid-suppressive therapy: higher incidence of respiratory infection

   Incidence study 23 January 2013 Pages: 4 - 4

9. HRT: increased stroke risk in hypertensive women

   Incidence study 23 January 2013 Pages: 4 - 4

10. Pilsicainide: ventricular arrhythmias in Brugada syndrome

    Clinical study 23 January 2013 Pages: 4 - 4

11. Sublingual immunotherapy `safe' for use in children

    Clinical study 23 January 2013 Pages: 4 - 4

12. Antiretrovirals: increased risk of myocardial infarction

    Clinical study 23 January 2013 Pages: 5 - 5

13. NSAIDs: oxicams greater risk of SJS and TEN

    Incidence study 23 January 2013 Pages: 5 - 5

14. Oncology drugs: dissemination of ADR information

    Non-clinical study 23 January 2013 Pages: 5 - 5

15. Aciclovir

    Case report 23 January 2013 Pages: 6 - 6

16. Amiodarone

    Case report 23 January 2013 Pages: 6 - 6

17. Amiodarone

    Case report 23 January 2013 Pages: 6 - 6

18. Amlodipine overdose

    Case report 23 January 2013 Pages: 6 - 7

19. Antiretroviral withdrawal

    Case reports 23 January 2013 Pages: 7 - 7

20. Aspirin/naproxen

    Case report 23 January 2013 Pages: 7 - 7

21. Azathioprine/cyclosporin/prednisolone

    Case report 23 January 2013 Pages: 7 - 8

22. Bethanechol chloride

    Case report 23 January 2013 Pages: 8 - 8

23. Buserelin/follitropin beta

    Case report 23 January 2013 Pages: 8 - 8

24. Carbamazepine

    Case report 23 January 2013 Pages: 8 - 9

25. Cetuximab

    Case reports 23 January 2013 Pages: 9 - 9

26. Cyclophosphamide

    Case report 23 January 2013 Pages: 9 - 9

27. Cytarabine

    Case report 23 January 2013 Pages: 9 - 9

28. Cytarabine/fludarabine/granulocyte colony-stimulating factor

    Case report 23 January 2013 Pages: 9 - 10

29. Dexketoprofen trometamol

    Case report 23 January 2013 Pages: 10 - 10

30. Docetaxel/paclitaxel

    Case reports 23 January 2013 Pages: 10 - 10

31. Donepezil

    Case reports 23 January 2013 Pages: 10 - 11

32. Dorzolamide

    Case report 23 January 2013 Pages: 11 - 11

33. Efavirenz/lamivudine/zidovudine

    Case report 23 January 2013 Pages: 11 - 11

34. Etanercept/infliximab

    Case reports 23 January 2013 Pages: 11 - 11

35. Ethosuximide

    Case report 23 January 2013 Pages: 11 - 12

36. Flecainide

    Case report 23 January 2013 Pages: 12 - 12

37. Fluindione interaction

    Case report 23 January 2013 Pages: 12 - 12

38. Gatifloxacin

    Case report 23 January 2013 Pages: 12 - 13

39. Gefitinib

    Case report 23 January 2013 Pages: 13 - 13

40. Haloperidol

    Case report 23 January 2013 Pages: 13 - 13

41. Herbal medicine

    Case report 23 January 2013 Pages: 13 - 13

42. Imatinib mesylate

    Case report 23 January 2013 Pages: 13 - 14

43. Immunoglobulins

    Case report 23 January 2013 Pages: 14 - 14

44. Ketoprofen

    Case report 23 January 2013 Pages: 14 - 14

45. Lansoprazole

    Case report 23 January 2013 Pages: 14 - 14

46. Letrozole/triptorelin

    Case report 23 January 2013 Pages: 14 - 15

47. Levofloxacin/ciprofloxacin

    Case report 23 January 2013 Pages: 15 - 15

48. Lorazepam

    Case report 23 January 2013 Pages: 15 - 15

49. Minocycline

    Case report 23 January 2013 Pages: 15 - 15

50. Moxifloxacin

    Case report 23 January 2013 Pages: 15 - 16